Atsushi Nakamura

Profiling Preexisting Antibodies in Patients Treated With Anti–PD-1 Therapy for Advanced Non–Small Cell Lung Cancer

Yukihiro Toi, Shunichi Sugawara, Jun Sugisaka et al. · JAMA Oncology · 2018 · 360 citations · Full text

Association of Immune-Related Adverse Events with Clinical Benefit in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Nivolumab

Yukihiro Toi, Shunichi Sugawara, Yosuke Kawashima et al. · The Oncologist · 2018 · 289 citations · Full text

Phase III study comparing gefitinib monotherapy (G) to combination therapy with gefitinib, carboplatin, and pemetrexed (GCP) for untreated patients (pts) with advanced non-small cell lung cancer (NSCLC) with EGFR mutations (NEJ009).

Atsushi Nakamura, Akira Inoue, Satoshi Morita et al. · Journal of Clinical Oncology · 2018 · 112 citations

Cancer Management, Gefitinib Monotherapy, Pathology +19

Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function

Atsushi Nakamura, Risa Ebina‐Shibuya, Ari Itoh‐Nakadai et al. · The Journal of Experimental Medicine · 2013 · 110 citations · Full text

Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC

Yasuto Yoneshima, Satoshi Morita, Masahiko Ando et al. · Journal of Thoracic Oncology · 2021 · 101 citations · Full text